These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23390217)

  • 1. Performance of endovenous foam sclerotherapy in the USA for the treatment of venous disorders: ACP/SVM/AVF/SIR quality improvement guidelines.
    Rathbun S; Norris A; Morrison N; Gibson K; Raymond-Martimbeau P; Worthington-Kirsch R; Hohenwalter E; Lohr J; McLafferty R; Stoner J
    Phlebology; 2014 Mar; 29(2):76-82. PubMed ID: 23390217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of endovenous foam sclerotherapy in the USA.
    Rathbun S; Norris A; Morrison N; Gibson K; Hohenwalter E; Lohr J; Raymond-Martimbeau P; Worthington-Kirsch R; Stoner J
    Phlebology; 2012 Mar; 27(2):59-66. PubMed ID: 21893552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.
    Rathbun S; Norris A; Stoner J
    Phlebology; 2012 Apr; 27(3):105-17. PubMed ID: 22349606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
    Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
    J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foam sclerotherapy.
    Alder G; Lees T
    Phlebology; 2015 Nov; 30(2 Suppl):18-23. PubMed ID: 26556698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European guidelines for sclerotherapy in chronic venous disorders.
    Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
    Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of foam sclerotherapy for the treatment of varicose veins.
    Nael R; Rathbun S
    Vasc Med; 2010 Feb; 15(1):27-32. PubMed ID: 19797263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid and Foam Sclerotherapy for Spider and Varicose Veins.
    Gibson K; Gunderson K
    Surg Clin North Am; 2018 Apr; 98(2):415-429. PubMed ID: 29502781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foam sclerotherapy--a possible option in therapy of varicose veins.
    Kendler M; Wetzig T; Simon JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):648-54. PubMed ID: 17659037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
    O'Hare JL; Earnshaw JJ
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):232-5. PubMed ID: 17507258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of published information on foam sclerotherapy.
    Stücker M; Kobus S; Altmeyer P; Reich-Schupke S
    Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux.
    Chapman-Smith P; Browne A
    Phlebology; 2009 Aug; 24(4):183-8. PubMed ID: 19620701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein.
    Atasoy MM
    Clin Radiol; 2015 Jan; 70(1):48-53. PubMed ID: 25446324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.
    Breu FX; Guggenbichler S; Wollmann JC;
    Vasa; 2008 Feb; 37(1):90-5. PubMed ID: 18512547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.
    Breu FX; Guggenbichler S
    Dermatol Surg; 2004 May; 30(5):709-17; discussion 717. PubMed ID: 15099312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerotherapy: a truly minimally invasive technique.
    Bergan J
    Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):70-2. PubMed ID: 18403470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.